Conditions: Actinic Keratosis
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 266
Healthy volunteers: no

Brief summary:
This is a randomised, double-blind, parallel groups, vehicle controlled, 8-week phase 2 trial. The objective is to evaluate efficacy of ingenol mebutate gel 0.06 % after once daily treatment for 2, 3 or 4 consecutive days compared to vehicle gel

Detailed description:

Arms:
arm 1: Placebo and drug arm 2: Placebo and drug arm 3: Placebo arm 4: Drug

Interventions: intervention 1: ingenol mebutate intervention 2: Placebo
Intervention descriptions: intervention 1: None intervention 2: None

Protocol document: